Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Philips Kumar
Institution:
Maharishi Markandeshwar University, Mullana
Observed institution:
Maharishi Markandeshwar University, Mullana
ORCID:
0009-0003-3552-0567
Observed ORCID:
0009-0003-3552-0567
OpenAlex ID:
A5128310577
Insights into the Recent Breakthroughs in Nanotechnological Outlook of Pentacyclic Triterpenoids: An Updated Approach
2026
·
Neelam Sharma
, Philips Kumar
, et al.
·
Current Pharmaceutical Design
·
2
Overview of pharmacogenomics and therapeutic drug monitoring
2026
·
Sukhbir Singh
, Neelam Sharma
, et al.
·
Elsevier eBooks
·
1
Deciphering the Pivotal Role of Nanoformulations of Vinca Alkaloids in Cancer: Preclinical, Clinical, and Patent Status
2026
·
Sukhbir Singh
, Samantha
, et al.
·
Letters in Applied NanoBioScience
PDF
Unraveling the Pharmacological Potential of Myricetin: From Therapeutic Applications to Recent Trends in Nanoformulations
2026
·
Neelam Sharma
, Gaurav Malik
, et al.
·
Letters in Applied NanoBioScience
PDF
Pharmacological and Nanotechnological Insights into SGLT-2 Inhibitors for Type 2 Diabetes Management
2026
·
Sukhbir Singh
, Sonam Grewal
, et al.
·
Letters in Applied NanoBioScience
PDF
Oncogenes and tumor suppressor genes: A futuristic approach toward cancer
2026
·
Neelam Sharma
, Sukhbir Singh
, et al.
·
Elsevier eBooks
Role of immunotherapy and immune checkpoint inhibitors in cancer therapy
2026
·
Sukhbir Singh
, Neelam Sharma
, et al.
·
Elsevier eBooks
Recent developments in clinical trials in personalized cancer therapy
2026
·
Neelam Sharma
, Sukhbir Singh
, et al.
·
Elsevier eBooks
Emerging trends in genomics and next-generation sequencing
2026
·
Neelam Sharma
, Sukhbir Singh
, et al.
·
Elsevier eBooks
Show more works
View as search
Works count:
10
Citation count:
3
H-index:
1
I10-index:
Year
Topic
Type